BioPharmaTrend
Latest News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers

Aruna Rajan

CEO at Arogyam LLC    


Aruna Rajan, founder of Arogyam has about two decades of experience helping companies in the healthcare sector make strategic decisions and accelerate ROI through guided assessments. She has extensive knowledge in the genomics, NGS, precision oncology, liquid biopsy, and the molecular diagnostics space. Strong ability in capturing customer insights, performing technical analysis, sizing niche segments, financial modeling, evaluating market dynamics, identify/evaluate new product potential, and presenting high impact, tactical recommendations.
Prior to Arogyam, Aruna worked in the market insights group at Illumina conducting market and competitive analyses to support senior executives, product marketing, investor relations and sales. Before Illumina, Aruna was a strategy consultant at Scientia Advisors, a boutique life science strategy consulting company.

Her primary expertise lies in providing strategic insights and actionable information to life science companies. Lead problem solving efforts by identifying issues, forming hypotheses, designing, and conducting analyses, synthesizing conclusions into recommendations.

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Latest articles from Aruna


Powered by Venture Funding, the Microbiome Market is Ready for Mainstream

April 15, 2021   
Powered by Venture Funding, the Microbiome Market is Ready for Mainstream

2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome research. In the year 2020, there were over 75K+ scientific publications, $1B+ grants awarded to microbiome research, ~150 ongoing clinical …

#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.